» Articles » PMID: 36625973

Cardiovascular Reflex Tests Detect Autonomic Dysfunction in Symptomatic and Pre-symptomatic Subjects with Hereditary Transthyretin Amyloidosis

Overview
Journal Clin Auton Res
Date 2023 Jan 10
PMID 36625973
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Autonomic dysfunction is a distinctive but undervalued feature of hereditary transthyretin amyloidosis (ATTRv). It may predate the onset of polyneuropathy and cardiomyopathy, thereby providing crucial prognostic and therapeutic information. The objective of this study was to assess autonomic function by means of the standardized cardiovascular autonomic reflex tests (CRTs) in a cohort of subjects with genetically proven ATTRv from non-endemic areas who were in the symptomatic and pre-symptomatic stages.

Methods: All subjects enrolled in this cross-sectional study had genetically proven ATTRv. They underwent the head-up tilt test, Valsalva manoeuvre, deep breathing test, cold face test and handgrip test while under continuous blood pressure and heart rate monitoring. Based on the results of the nerve conduction study, the subjects were divided into two groups: those with polyneuropathy (ATTRv-wPN) and those without polyneuropathy (ATTRv-woPN). Age- and sex-matched healthy controls (HC) were used for comparison.

Results: Thirty-seven ATTRv subjects (19 with ATTRv-wPN, 18 with ATTRv-woPN) and 41 HC performed the CRTs. Of these 37 subjects with ATTRv, four (11%) presented neurogenic orthostatic hypotension the during head-up tilt test. Based on the results of the CRTs, autonomic dysfunction characterized by either sympathetic or parasympathetic impairment was detected in 37% and 63% of ATTRv-wPN subjects, respectively. Subjects with ATTRv-woPN presented a significant impairment of autonomic responses to the Valsalva manoeuvre compared to the HC (overshoot p = 0.004; Valsalva ratio p = 0.001).

Conclusion: Autonomic dysfunctions are frequent in subjects with ATTRv when investigated by means of standardized CRTs, and are also relevant in the pre-symptomatic stage. Cardiovagal functions are the primary functions affected, among others. This may be crucial in defining the proper diagnostic workout for early diagnosis and improving the likelihood of providing the patient with prompt administration of disease-modifying treatments.

Citing Articles

Examination of the autonomic nervous system at the bedside.

Panigrahi B, Srivastava A, Garg D, Jaryal A Acta Neurol Belg. 2024; .

PMID: 39636352 DOI: 10.1007/s13760-024-02654-2.


Patisiran for the treatment of patients with p.Ile88Leu hereditary transthyretin amyloidosis: an Italian real-life experience.

Urbinati G, Cani I, Curro Dossi M, Longhi S, Carigi S, Gagliardi C Front Neurol. 2024; 15:1415851.

PMID: 38911588 PMC: 11193553. DOI: 10.3389/fneur.2024.1415851.


Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.

Chiaro G, Stancanelli C, Koay S, Vichayanrat E, Sander L, Ingle G Clin Auton Res. 2024; 34(3):341-352.

PMID: 38769233 DOI: 10.1007/s10286-024-01038-z.


Early autonomic biomarkers in ATTRv carriers.

Gonzalez-Duarte A, Norcliffe-Kauffman L Clin Auton Res. 2023; 33(1):9-10.

PMID: 36719509 DOI: 10.1007/s10286-023-00926-0.

References
1.
Carroll A, Dyck P, de Carvalho M, Kennerson M, Reilly M, Kiernan M . Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. J Neurol Neurosurg Psychiatry. 2022; 93(6):668-678. PMC: 9148983. DOI: 10.1136/jnnp-2021-327909. View

2.
Sekijima Y, Wiseman R, Matteson J, Hammarstrom P, Miller S, Sawkar A . The biological and chemical basis for tissue-selective amyloid disease. Cell. 2005; 121(1):73-85. DOI: 10.1016/j.cell.2005.01.018. View

3.
Barroso F, Coelho T, Dispenzieri A, Conceicao I, Waddington-Cruz M, Wixner J . Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS). Amyloid. 2022; 29(3):175-183. DOI: 10.1080/13506129.2022.2043270. View

4.
Palma J, Gonzalez-Duarte A, Kaufmann H . Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management. Clin Auton Res. 2019; 29(Suppl 1):33-44. PMC: 6763509. DOI: 10.1007/s10286-019-00623-x. View

5.
Algalarrondo V, Antonini T, Theaudin M, Chemla D, Benmalek A, Lacroix C . Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation. JACC Cardiovasc Imaging. 2016; 9(12):1432-1441. DOI: 10.1016/j.jcmg.2016.07.008. View